Cite
APA Citation
Hu, S., Gu, S., Qi, C., Wang, S., Qian, F., Shi, C., & Fan, G. (2023). cost‐utility analysis of semaglutide for type 2 diabetes after its addition to the National Medical Insurance System in China. Diabetes, obesity & metabolism, 25(2), 387–397. http://access.bl.uk/ark:/81055/vdc_100174258417.0x000017